Trials / Completed
CompletedNCT02891356
Bone Mass Changes in Anorexia Nervosa Patient Followed During 4 Years
Bone Mass Changes in Anorexia Nervosa Patient Followed During 4 Years and Relationship Between Bone Loss and Adipokines.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 180 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The mechanism of bone loss in anorexia nervosa is complex. Marrow adipose tissue seems to play a role in the regulation of bone metabolism. Adipocytes secrete cytokines and adipokines that either stimulate or inhibit adjacent osteoblasts. This study consist to explore the relationship in anorexia nervosa patients with change in bone mineral density and adipokines like leptin, adiponectin and Préf-1 Bone mineral densities will be measure in 180 anorexia nervosa patients at inclusion and every two years during 6 years.It is assessed blood and urinary calcium and phosphate levels, bone remodelling markers and adipokines (leptin, adiponectin and Préf-1)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DEXA | The Dual Energy X-ray Absorptiometry (DEXA) is a third generation multi-captor DEXA device that allow short duration measurements. It measures Bone Mineral Density (BMD) at the spine and the femoral neck |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
- First posted
- 2016-09-07
- Last updated
- 2025-12-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02891356. Inclusion in this directory is not an endorsement.